Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing
News provided by
Share this article
Share this article
SAN FRANCISCO, April 29, 2021 /PRNewswire/ Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF.
Currently, PGT-A genetic testing requires a portion of a healthy embryo to be removed and sent away for testing. The procedure is invasive, costly, and potentially risky.
Presagen CEO, Dr Michelle Perugini said: Some future parents are just not comfortable with the thought of having to biopsy their embryo, which may ultimately become their baby. PGT-A testing is conducted because evidence suggests genetically healthy embryos can increase pregnancy success and reduce miscarriage for IVF patients who are desperate for children.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CHNC Saga, Metamorphosis, and Transformation
China Infrastructure Construction Corp.February 5, 2021 GMT
HOUSTON, Texas, Feb. 05, 2021 (GLOBE NEWSWIRE) via NewMediaWire China Infrastructure Construction Corp. (OTC: CHNC) https://www.chnc-hdh.com/ CHNC has finally reconstructed itself; it seems as if it was only yesterday when on December 19, 2019 Pharmacology University concluded its merger with CHNC. As established during negotiations, Pharmacology University also appropriated responsibility for the management of the company and though we planned for difficulties, we did not budget for calamitous. Since then, we started to peel the onion and the more we did, the more it stunk. Particularly, because CHNC had a $1,844,500 debt, a Shell Risk designation meaning the company had no or minimal assets and operations, no employees to speak of, and during the calendar year of 2019 the comp